Pharma & Healthcare
Global Mealtime Insulin Market Research Report 2026
- Mar 17, 26
- ID: 737579
- Pages: 120
- Figures: 127
- Views: 6
This report delivers a comprehensive overview of the global Mealtime Insulin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mealtime Insulin. The Mealtime Insulin market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mealtime Insulin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mealtime Insulin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Eli Lilly
Novo Nordisk
Sanofi
Biocon Biologics
Wockhardt
Bayer
Pfizer
BASF
Abbott Laboratories
Tonghua Dongbao Pharmaceutical
Zhuhai United Pharmaceutical
Sinovac Biotech
Wanbang Biopharmaceuticals
HTBT
Gan & Lee Pharmaceuticals
Segment by Type
Rapid-acting Insulin Analogs
Short-acting Insulin
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mealtime Insulin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mealtime Insulin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Mealtime Insulin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mealtime Insulin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Eli Lilly
Novo Nordisk
Sanofi
Biocon Biologics
Wockhardt
Bayer
Pfizer
BASF
Abbott Laboratories
Tonghua Dongbao Pharmaceutical
Zhuhai United Pharmaceutical
Sinovac Biotech
Wanbang Biopharmaceuticals
HTBT
Gan & Lee Pharmaceuticals
Segment by Type
Rapid-acting Insulin Analogs
Short-acting Insulin
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mealtime Insulin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mealtime Insulin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Mealtime Insulin Market Overview
1.1 Product Definition
1.2 Mealtime Insulin by Type
1.2.1 Global Mealtime Insulin Market Value by Type: 2025 vs 2032
1.2.2 Rapid-acting Insulin Analogs
1.2.3 Short-acting Insulin
1.3 Mealtime Insulin by Application
1.3.1 Global Mealtime Insulin Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Mealtime Insulin Market Size Estimates and Forecasts
1.4.1 Global Mealtime Insulin Revenue 2021–2032
1.4.2 Global Mealtime Insulin Sales 2021–2032
1.4.3 Global Mealtime Insulin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mealtime Insulin Market Competition by Manufacturers
2.1 Global Mealtime Insulin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mealtime Insulin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mealtime Insulin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mealtime Insulin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mealtime Insulin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mealtime Insulin, Product Types and Applications
2.7 Global Key Manufacturers of Mealtime Insulin, Date of Entry into the Industry
2.8 Global Mealtime Insulin Market Competitive Situation and Trends
2.8.1 Global Mealtime Insulin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mealtime Insulin Players Market Share by Revenue
2.8.3 Global Mealtime Insulin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mealtime Insulin Market Scenario by Region
3.1 Global Mealtime Insulin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mealtime Insulin Sales by Region: 2021–2032
3.2.1 Global Mealtime Insulin Sales by Region: 2021–2026
3.2.2 Global Mealtime Insulin Sales by Region: 2027–2032
3.3 Global Mealtime Insulin Revenue by Region: 2021–2032
3.3.1 Global Mealtime Insulin Revenue by Region: 2021–2026
3.3.2 Global Mealtime Insulin Revenue by Region: 2027–2032
3.4 North America Mealtime Insulin Market Facts & Figures by Country
3.4.1 North America Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mealtime Insulin Sales by Country (2021–2032)
3.4.3 North America Mealtime Insulin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mealtime Insulin Market Facts & Figures by Country
3.5.1 Europe Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mealtime Insulin Sales by Country (2021–2032)
3.5.3 Europe Mealtime Insulin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mealtime Insulin Market Facts & Figures by Region
3.6.1 Asia Pacific Mealtime Insulin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mealtime Insulin Sales by Region (2021–2032)
3.6.3 Asia Pacific Mealtime Insulin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mealtime Insulin Market Facts & Figures by Country
3.7.1 Latin America Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mealtime Insulin Sales by Country (2021–2032)
3.7.3 Latin America Mealtime Insulin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mealtime Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mealtime Insulin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mealtime Insulin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mealtime Insulin Sales by Type (2021–2032)
4.1.1 Global Mealtime Insulin Sales by Type (2021–2026)
4.1.2 Global Mealtime Insulin Sales by Type (2027–2032)
4.1.3 Global Mealtime Insulin Sales Market Share by Type (2021–2032)
4.2 Global Mealtime Insulin Revenue by Type (2021–2032)
4.2.1 Global Mealtime Insulin Revenue by Type (2021–2026)
4.2.2 Global Mealtime Insulin Revenue by Type (2027–2032)
4.2.3 Global Mealtime Insulin Revenue Market Share by Type (2021–2032)
4.3 Global Mealtime Insulin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mealtime Insulin Sales by Application (2021–2032)
5.1.1 Global Mealtime Insulin Sales by Application (2021–2026)
5.1.2 Global Mealtime Insulin Sales by Application (2027–2032)
5.1.3 Global Mealtime Insulin Sales Market Share by Application (2021–2032)
5.2 Global Mealtime Insulin Revenue by Application (2021–2032)
5.2.1 Global Mealtime Insulin Revenue by Application (2021–2026)
5.2.2 Global Mealtime Insulin Revenue by Application (2027–2032)
5.2.3 Global Mealtime Insulin Revenue Market Share by Application (2021–2032)
5.3 Global Mealtime Insulin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eli Lilly Mealtime Insulin Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Company Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novo Nordisk Mealtime Insulin Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sanofi Mealtime Insulin Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Biocon Biologics
6.4.1 Biocon Biologics Company Information
6.4.2 Biocon Biologics Description and Business Overview
6.4.3 Biocon Biologics Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Biocon Biologics Mealtime Insulin Product Portfolio
6.4.5 Biocon Biologics Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Company Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wockhardt Mealtime Insulin Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bayer Mealtime Insulin Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Mealtime Insulin Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 BASF
6.8.1 BASF Company Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BASF Mealtime Insulin Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Company Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Abbott Laboratories Mealtime Insulin Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Tonghua Dongbao Pharmaceutical
6.10.1 Tonghua Dongbao Pharmaceutical Company Information
6.10.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.10.3 Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio
6.10.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.11 Zhuhai United Pharmaceutical
6.11.1 Zhuhai United Pharmaceutical Company Information
6.11.2 Zhuhai United Pharmaceutical Description and Business Overview
6.11.3 Zhuhai United Pharmaceutical Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio
6.11.5 Zhuhai United Pharmaceutical Recent Developments/Updates
6.12 Sinovac Biotech
6.12.1 Sinovac Biotech Company Information
6.12.2 Sinovac Biotech Description and Business Overview
6.12.3 Sinovac Biotech Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinovac Biotech Mealtime Insulin Product Portfolio
6.12.5 Sinovac Biotech Recent Developments/Updates
6.13 Wanbang Biopharmaceuticals
6.13.1 Wanbang Biopharmaceuticals Company Information
6.13.2 Wanbang Biopharmaceuticals Description and Business Overview
6.13.3 Wanbang Biopharmaceuticals Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio
6.13.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.14 HTBT
6.14.1 HTBT Company Information
6.14.2 HTBT Description and Business Overview
6.14.3 HTBT Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 HTBT Mealtime Insulin Product Portfolio
6.14.5 HTBT Recent Developments/Updates
6.15 Gan & Lee Pharmaceuticals
6.15.1 Gan & Lee Pharmaceuticals Company Information
6.15.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.15.3 Gan & Lee Pharmaceuticals Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio
6.15.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mealtime Insulin Industry Chain Analysis
7.2 Mealtime Insulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mealtime Insulin Production Mode & Process Analysis
7.4 Mealtime Insulin Sales and Marketing
7.4.1 Mealtime Insulin Sales Channels
7.4.2 Mealtime Insulin Distributors
7.5 Mealtime Insulin Customer Analysis
8 Mealtime Insulin Market Dynamics
8.1 Mealtime Insulin Industry Trends
8.2 Mealtime Insulin Market Drivers
8.3 Mealtime Insulin Market Challenges
8.4 Mealtime Insulin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Mealtime Insulin by Type
1.2.1 Global Mealtime Insulin Market Value by Type: 2025 vs 2032
1.2.2 Rapid-acting Insulin Analogs
1.2.3 Short-acting Insulin
1.3 Mealtime Insulin by Application
1.3.1 Global Mealtime Insulin Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Mealtime Insulin Market Size Estimates and Forecasts
1.4.1 Global Mealtime Insulin Revenue 2021–2032
1.4.2 Global Mealtime Insulin Sales 2021–2032
1.4.3 Global Mealtime Insulin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mealtime Insulin Market Competition by Manufacturers
2.1 Global Mealtime Insulin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mealtime Insulin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mealtime Insulin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mealtime Insulin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mealtime Insulin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mealtime Insulin, Product Types and Applications
2.7 Global Key Manufacturers of Mealtime Insulin, Date of Entry into the Industry
2.8 Global Mealtime Insulin Market Competitive Situation and Trends
2.8.1 Global Mealtime Insulin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mealtime Insulin Players Market Share by Revenue
2.8.3 Global Mealtime Insulin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mealtime Insulin Market Scenario by Region
3.1 Global Mealtime Insulin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mealtime Insulin Sales by Region: 2021–2032
3.2.1 Global Mealtime Insulin Sales by Region: 2021–2026
3.2.2 Global Mealtime Insulin Sales by Region: 2027–2032
3.3 Global Mealtime Insulin Revenue by Region: 2021–2032
3.3.1 Global Mealtime Insulin Revenue by Region: 2021–2026
3.3.2 Global Mealtime Insulin Revenue by Region: 2027–2032
3.4 North America Mealtime Insulin Market Facts & Figures by Country
3.4.1 North America Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mealtime Insulin Sales by Country (2021–2032)
3.4.3 North America Mealtime Insulin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mealtime Insulin Market Facts & Figures by Country
3.5.1 Europe Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mealtime Insulin Sales by Country (2021–2032)
3.5.3 Europe Mealtime Insulin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mealtime Insulin Market Facts & Figures by Region
3.6.1 Asia Pacific Mealtime Insulin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mealtime Insulin Sales by Region (2021–2032)
3.6.3 Asia Pacific Mealtime Insulin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mealtime Insulin Market Facts & Figures by Country
3.7.1 Latin America Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mealtime Insulin Sales by Country (2021–2032)
3.7.3 Latin America Mealtime Insulin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mealtime Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Mealtime Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mealtime Insulin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mealtime Insulin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mealtime Insulin Sales by Type (2021–2032)
4.1.1 Global Mealtime Insulin Sales by Type (2021–2026)
4.1.2 Global Mealtime Insulin Sales by Type (2027–2032)
4.1.3 Global Mealtime Insulin Sales Market Share by Type (2021–2032)
4.2 Global Mealtime Insulin Revenue by Type (2021–2032)
4.2.1 Global Mealtime Insulin Revenue by Type (2021–2026)
4.2.2 Global Mealtime Insulin Revenue by Type (2027–2032)
4.2.3 Global Mealtime Insulin Revenue Market Share by Type (2021–2032)
4.3 Global Mealtime Insulin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mealtime Insulin Sales by Application (2021–2032)
5.1.1 Global Mealtime Insulin Sales by Application (2021–2026)
5.1.2 Global Mealtime Insulin Sales by Application (2027–2032)
5.1.3 Global Mealtime Insulin Sales Market Share by Application (2021–2032)
5.2 Global Mealtime Insulin Revenue by Application (2021–2032)
5.2.1 Global Mealtime Insulin Revenue by Application (2021–2026)
5.2.2 Global Mealtime Insulin Revenue by Application (2027–2032)
5.2.3 Global Mealtime Insulin Revenue Market Share by Application (2021–2032)
5.3 Global Mealtime Insulin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eli Lilly Mealtime Insulin Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Company Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novo Nordisk Mealtime Insulin Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sanofi Mealtime Insulin Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Biocon Biologics
6.4.1 Biocon Biologics Company Information
6.4.2 Biocon Biologics Description and Business Overview
6.4.3 Biocon Biologics Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Biocon Biologics Mealtime Insulin Product Portfolio
6.4.5 Biocon Biologics Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Company Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wockhardt Mealtime Insulin Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bayer Mealtime Insulin Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Mealtime Insulin Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 BASF
6.8.1 BASF Company Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BASF Mealtime Insulin Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Company Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Abbott Laboratories Mealtime Insulin Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Tonghua Dongbao Pharmaceutical
6.10.1 Tonghua Dongbao Pharmaceutical Company Information
6.10.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.10.3 Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio
6.10.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.11 Zhuhai United Pharmaceutical
6.11.1 Zhuhai United Pharmaceutical Company Information
6.11.2 Zhuhai United Pharmaceutical Description and Business Overview
6.11.3 Zhuhai United Pharmaceutical Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio
6.11.5 Zhuhai United Pharmaceutical Recent Developments/Updates
6.12 Sinovac Biotech
6.12.1 Sinovac Biotech Company Information
6.12.2 Sinovac Biotech Description and Business Overview
6.12.3 Sinovac Biotech Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinovac Biotech Mealtime Insulin Product Portfolio
6.12.5 Sinovac Biotech Recent Developments/Updates
6.13 Wanbang Biopharmaceuticals
6.13.1 Wanbang Biopharmaceuticals Company Information
6.13.2 Wanbang Biopharmaceuticals Description and Business Overview
6.13.3 Wanbang Biopharmaceuticals Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio
6.13.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.14 HTBT
6.14.1 HTBT Company Information
6.14.2 HTBT Description and Business Overview
6.14.3 HTBT Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 HTBT Mealtime Insulin Product Portfolio
6.14.5 HTBT Recent Developments/Updates
6.15 Gan & Lee Pharmaceuticals
6.15.1 Gan & Lee Pharmaceuticals Company Information
6.15.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.15.3 Gan & Lee Pharmaceuticals Mealtime Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio
6.15.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mealtime Insulin Industry Chain Analysis
7.2 Mealtime Insulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mealtime Insulin Production Mode & Process Analysis
7.4 Mealtime Insulin Sales and Marketing
7.4.1 Mealtime Insulin Sales Channels
7.4.2 Mealtime Insulin Distributors
7.5 Mealtime Insulin Customer Analysis
8 Mealtime Insulin Market Dynamics
8.1 Mealtime Insulin Industry Trends
8.2 Mealtime Insulin Market Drivers
8.3 Mealtime Insulin Market Challenges
8.4 Mealtime Insulin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mealtime Insulin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mealtime Insulin Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Mealtime Insulin Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mealtime Insulin Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Mealtime Insulin Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mealtime Insulin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mealtime Insulin Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mealtime Insulin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mealtime Insulin, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mealtime Insulin, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mealtime Insulin, Product Types and Applications
Table 12. Global Key Manufacturers of Mealtime Insulin, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mealtime Insulin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mealtime Insulin Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mealtime Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mealtime Insulin Sales by Region (K Units), 2021–2026
Table 18. Global Mealtime Insulin Sales Market Share by Region (2021–2026)
Table 19. Global Mealtime Insulin Sales by Region (K Units), 2027–2032
Table 20. Global Mealtime Insulin Sales Market Share by Region (2027–2032)
Table 21. Global Mealtime Insulin Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mealtime Insulin Revenue Market Share by Region (2021–2026)
Table 23. Global Mealtime Insulin Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mealtime Insulin Revenue Market Share by Region (2027–2032)
Table 25. North America Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 27. North America Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 28. North America Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 32. Europe Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 33. Europe Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mealtime Insulin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mealtime Insulin Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Mealtime Insulin Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Mealtime Insulin Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mealtime Insulin Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 42. Latin America Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 43. Latin America Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mealtime Insulin Sales (K Units) by Type (2021–2026)
Table 51. Global Mealtime Insulin Sales (K Units) by Type (2027–2032)
Table 52. Global Mealtime Insulin Sales Market Share by Type (2021–2026)
Table 53. Global Mealtime Insulin Sales Market Share by Type (2027–2032)
Table 54. Global Mealtime Insulin Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mealtime Insulin Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mealtime Insulin Revenue Market Share by Type (2021–2026)
Table 57. Global Mealtime Insulin Revenue Market Share by Type (2027–2032)
Table 58. Global Mealtime Insulin Price (US$/Unit) by Type (2021–2026)
Table 59. Global Mealtime Insulin Price (US$/Unit) by Type (2027–2032)
Table 60. Global Mealtime Insulin Sales (K Units) by Application (2021–2026)
Table 61. Global Mealtime Insulin Sales (K Units) by Application (2027–2032)
Table 62. Global Mealtime Insulin Sales Market Share by Application (2021–2026)
Table 63. Global Mealtime Insulin Sales Market Share by Application (2027–2032)
Table 64. Global Mealtime Insulin Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Mealtime Insulin Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Mealtime Insulin Revenue Market Share by Application (2021–2026)
Table 67. Global Mealtime Insulin Revenue Market Share by Application (2027–2032)
Table 68. Global Mealtime Insulin Price (US$/Unit) by Application (2021–2026)
Table 69. Global Mealtime Insulin Price (US$/Unit) by Application (2027–2032)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Eli Lilly Mealtime Insulin Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Novo Nordisk Company Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novo Nordisk Mealtime Insulin Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sanofi Mealtime Insulin Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Biocon Biologics Company Information
Table 86. Biocon Biologics Description and Business Overview
Table 87. Biocon Biologics Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Biocon Biologics Mealtime Insulin Product
Table 89. Biocon Biologics Recent Developments/Updates
Table 90. Wockhardt Company Information
Table 91. Wockhardt Description and Business Overview
Table 92. Wockhardt Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Wockhardt Mealtime Insulin Product
Table 94. Wockhardt Recent Developments/Updates
Table 95. Bayer Company Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Bayer Mealtime Insulin Product
Table 99. Bayer Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Mealtime Insulin Product
Table 104. Pfizer Recent Developments/Updates
Table 105. BASF Company Information
Table 106. BASF Description and Business Overview
Table 107. BASF Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. BASF Mealtime Insulin Product
Table 109. BASF Recent Developments/Updates
Table 110. Abbott Laboratories Company Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Abbott Laboratories Mealtime Insulin Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Tonghua Dongbao Pharmaceutical Company Information
Table 116. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 117. Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Tonghua Dongbao Pharmaceutical Mealtime Insulin Product
Table 119. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 120. Zhuhai United Pharmaceutical Company Information
Table 121. Zhuhai United Pharmaceutical Description and Business Overview
Table 122. Zhuhai United Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Zhuhai United Pharmaceutical Mealtime Insulin Product
Table 124. Zhuhai United Pharmaceutical Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sinovac Biotech Mealtime Insulin Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Wanbang Biopharmaceuticals Company Information
Table 131. Wanbang Biopharmaceuticals Description and Business Overview
Table 132. Wanbang Biopharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Wanbang Biopharmaceuticals Mealtime Insulin Product
Table 134. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 135. HTBT Company Information
Table 136. HTBT Description and Business Overview
Table 137. HTBT Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. HTBT Mealtime Insulin Product
Table 139. HTBT Recent Developments/Updates
Table 140. Gan & Lee Pharmaceuticals Company Information
Table 141. Gan & Lee Pharmaceuticals Description and Business Overview
Table 142. Gan & Lee Pharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Gan & Lee Pharmaceuticals Mealtime Insulin Product
Table 144. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Mealtime Insulin Distributors List
Table 148. Mealtime Insulin Customers List
Table 149. Mealtime Insulin Market Trends
Table 150. Mealtime Insulin Market Drivers
Table 151. Mealtime Insulin Market Challenges
Table 152. Mealtime Insulin Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mealtime Insulin
Figure 2. Global Mealtime Insulin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mealtime Insulin Market Share by Type: 2025 & 2032
Figure 4. Rapid-acting Insulin Analogs Product Picture
Figure 5. Short-acting Insulin Product Picture
Figure 6. Global Mealtime Insulin Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Mealtime Insulin Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Mealtime Insulin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Mealtime Insulin Market Size (US$ Million), 2021–2032
Figure 13. Global Mealtime Insulin Sales (K Units), 2021–2032
Figure 14. Global Mealtime Insulin Average Price (US$/Unit), 2021–2032
Figure 15. Mealtime Insulin Report Years Considered
Figure 16. Mealtime Insulin Sales Share by Manufacturers in 2025
Figure 17. Global Mealtime Insulin Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Mealtime Insulin Players: Market Share by Revenue in Mealtime Insulin in 2025
Figure 19. Mealtime Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Mealtime Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 22. North America Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 23. United States Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 26. Europe Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 27. Germany Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Mealtime Insulin Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Mealtime Insulin Revenue Market Share by Region (2021–2032)
Figure 34. China Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 42. Latin America Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Mealtime Insulin by Type (2021–2032)
Figure 53. Global Revenue Market Share of Mealtime Insulin by Type (2021–2032)
Figure 54. Global Mealtime Insulin Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Mealtime Insulin by Application (2021–2032)
Figure 56. Global Revenue Market Share of Mealtime Insulin by Application (2021–2032)
Figure 57. Global Mealtime Insulin Price (US$/Unit) by Application (2021–2032)
Figure 58. Mealtime Insulin Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Mealtime Insulin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mealtime Insulin Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Mealtime Insulin Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mealtime Insulin Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Mealtime Insulin Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mealtime Insulin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mealtime Insulin Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mealtime Insulin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mealtime Insulin, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mealtime Insulin, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mealtime Insulin, Product Types and Applications
Table 12. Global Key Manufacturers of Mealtime Insulin, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mealtime Insulin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mealtime Insulin Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mealtime Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mealtime Insulin Sales by Region (K Units), 2021–2026
Table 18. Global Mealtime Insulin Sales Market Share by Region (2021–2026)
Table 19. Global Mealtime Insulin Sales by Region (K Units), 2027–2032
Table 20. Global Mealtime Insulin Sales Market Share by Region (2027–2032)
Table 21. Global Mealtime Insulin Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mealtime Insulin Revenue Market Share by Region (2021–2026)
Table 23. Global Mealtime Insulin Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mealtime Insulin Revenue Market Share by Region (2027–2032)
Table 25. North America Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 27. North America Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 28. North America Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 32. Europe Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 33. Europe Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mealtime Insulin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mealtime Insulin Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Mealtime Insulin Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Mealtime Insulin Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mealtime Insulin Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 42. Latin America Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 43. Latin America Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mealtime Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mealtime Insulin Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Mealtime Insulin Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Mealtime Insulin Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mealtime Insulin Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mealtime Insulin Sales (K Units) by Type (2021–2026)
Table 51. Global Mealtime Insulin Sales (K Units) by Type (2027–2032)
Table 52. Global Mealtime Insulin Sales Market Share by Type (2021–2026)
Table 53. Global Mealtime Insulin Sales Market Share by Type (2027–2032)
Table 54. Global Mealtime Insulin Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mealtime Insulin Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mealtime Insulin Revenue Market Share by Type (2021–2026)
Table 57. Global Mealtime Insulin Revenue Market Share by Type (2027–2032)
Table 58. Global Mealtime Insulin Price (US$/Unit) by Type (2021–2026)
Table 59. Global Mealtime Insulin Price (US$/Unit) by Type (2027–2032)
Table 60. Global Mealtime Insulin Sales (K Units) by Application (2021–2026)
Table 61. Global Mealtime Insulin Sales (K Units) by Application (2027–2032)
Table 62. Global Mealtime Insulin Sales Market Share by Application (2021–2026)
Table 63. Global Mealtime Insulin Sales Market Share by Application (2027–2032)
Table 64. Global Mealtime Insulin Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Mealtime Insulin Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Mealtime Insulin Revenue Market Share by Application (2021–2026)
Table 67. Global Mealtime Insulin Revenue Market Share by Application (2027–2032)
Table 68. Global Mealtime Insulin Price (US$/Unit) by Application (2021–2026)
Table 69. Global Mealtime Insulin Price (US$/Unit) by Application (2027–2032)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Eli Lilly Mealtime Insulin Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Novo Nordisk Company Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novo Nordisk Mealtime Insulin Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sanofi Mealtime Insulin Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Biocon Biologics Company Information
Table 86. Biocon Biologics Description and Business Overview
Table 87. Biocon Biologics Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Biocon Biologics Mealtime Insulin Product
Table 89. Biocon Biologics Recent Developments/Updates
Table 90. Wockhardt Company Information
Table 91. Wockhardt Description and Business Overview
Table 92. Wockhardt Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Wockhardt Mealtime Insulin Product
Table 94. Wockhardt Recent Developments/Updates
Table 95. Bayer Company Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Bayer Mealtime Insulin Product
Table 99. Bayer Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Mealtime Insulin Product
Table 104. Pfizer Recent Developments/Updates
Table 105. BASF Company Information
Table 106. BASF Description and Business Overview
Table 107. BASF Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. BASF Mealtime Insulin Product
Table 109. BASF Recent Developments/Updates
Table 110. Abbott Laboratories Company Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Abbott Laboratories Mealtime Insulin Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Tonghua Dongbao Pharmaceutical Company Information
Table 116. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 117. Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Tonghua Dongbao Pharmaceutical Mealtime Insulin Product
Table 119. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 120. Zhuhai United Pharmaceutical Company Information
Table 121. Zhuhai United Pharmaceutical Description and Business Overview
Table 122. Zhuhai United Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Zhuhai United Pharmaceutical Mealtime Insulin Product
Table 124. Zhuhai United Pharmaceutical Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sinovac Biotech Mealtime Insulin Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Wanbang Biopharmaceuticals Company Information
Table 131. Wanbang Biopharmaceuticals Description and Business Overview
Table 132. Wanbang Biopharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Wanbang Biopharmaceuticals Mealtime Insulin Product
Table 134. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 135. HTBT Company Information
Table 136. HTBT Description and Business Overview
Table 137. HTBT Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. HTBT Mealtime Insulin Product
Table 139. HTBT Recent Developments/Updates
Table 140. Gan & Lee Pharmaceuticals Company Information
Table 141. Gan & Lee Pharmaceuticals Description and Business Overview
Table 142. Gan & Lee Pharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Gan & Lee Pharmaceuticals Mealtime Insulin Product
Table 144. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Mealtime Insulin Distributors List
Table 148. Mealtime Insulin Customers List
Table 149. Mealtime Insulin Market Trends
Table 150. Mealtime Insulin Market Drivers
Table 151. Mealtime Insulin Market Challenges
Table 152. Mealtime Insulin Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mealtime Insulin
Figure 2. Global Mealtime Insulin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mealtime Insulin Market Share by Type: 2025 & 2032
Figure 4. Rapid-acting Insulin Analogs Product Picture
Figure 5. Short-acting Insulin Product Picture
Figure 6. Global Mealtime Insulin Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Mealtime Insulin Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Mealtime Insulin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Mealtime Insulin Market Size (US$ Million), 2021–2032
Figure 13. Global Mealtime Insulin Sales (K Units), 2021–2032
Figure 14. Global Mealtime Insulin Average Price (US$/Unit), 2021–2032
Figure 15. Mealtime Insulin Report Years Considered
Figure 16. Mealtime Insulin Sales Share by Manufacturers in 2025
Figure 17. Global Mealtime Insulin Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Mealtime Insulin Players: Market Share by Revenue in Mealtime Insulin in 2025
Figure 19. Mealtime Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Mealtime Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 22. North America Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 23. United States Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 26. Europe Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 27. Germany Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Mealtime Insulin Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Mealtime Insulin Revenue Market Share by Region (2021–2032)
Figure 34. China Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 42. Latin America Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Mealtime Insulin Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Mealtime Insulin Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Mealtime Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Mealtime Insulin by Type (2021–2032)
Figure 53. Global Revenue Market Share of Mealtime Insulin by Type (2021–2032)
Figure 54. Global Mealtime Insulin Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Mealtime Insulin by Application (2021–2032)
Figure 56. Global Revenue Market Share of Mealtime Insulin by Application (2021–2032)
Figure 57. Global Mealtime Insulin Price (US$/Unit) by Application (2021–2032)
Figure 58. Mealtime Insulin Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232